on INVENTIVA (EPA:IVA)
Inventiva at the Jefferies and UBS Healthcare Conferences

On May 27, 2025, Inventiva, a French biopharmaceutical company listed on Euronext Paris and Nasdaq, announced its participation in the Jefferies Global Healthcare Conference and the UBS Spring Biotech Conference in June 2025. Specializing in the treatment of metabolic steatohepatitis (MASH), the company seeks to offer innovative therapeutic solutions.
Frédéric Cren, CEO and co-founder, will present the company's strategies during a fireside chat at the Jefferies conference on June 4 in New York. This event will be streamed live on Inventiva's website. The company will also participate in the UBS conference on June 24.
R. P.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all INVENTIVA news